Full Text
PHP60 ORPHAN DRUGS FACE TOUGHER SCRUTINY IN SECURING FAVORABLE PRICING AND MARKET ACCESS

Abstract

Authors

A. Grosvenor S. Saraf K. Jones

Back to Volume 14, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×